Generic name: phentolamine mesylate
Dosage form: injection, solution
This dosage information does not include all the information needed to use OraVerse safely and effectively. See full prescribing information for OraVerse.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
General Dosing information
The recommended dose of OraVerse is based on the number of cartridges of local anesthetic with vasoconstrictor administered:
|Amount of Local Anesthetic Administered||Dose of OraVerse [mg]||Dose of OraVerse [Cartridge(s)]|
OraVerse should be administered following the dental procedure using the same location(s) and technique(s) (infiltration or block injection) employed for the administration of the local anesthetic.
Note: Do not administer OraVerse if the product is discolored or contains particulate matter.
Dosing in Special Populations
In pediatric patients weighing 15-30 kg, the maximum dose of OraVerse recommended is 1/2 cartridge (0.2 mg).
(Note: Use in pediatric patients under 6 years of age or weighing less than15 kg (33 lbs) is not recommended. A dose of more than 1 cartridge [0.4 mg] of OraVerse has not been studied in children less than 12 years of age.)